The particulars: ERP · KP · Finland.
I suspect the honest answer is that it depends, in which case I would like to know on what.
Assume I can obtain either option without difficulty, so availability is not the deciding factor.
What is the actual trade-off, and does it matter at the scale I am working at?
The short version: same compound, same laboratory, same method, ideally same week — otherwise you are comparing laboratories rather than suppliers.
Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.
| Observation | Implication | How to check |
|---|---|---|
| Lot number not on the vial | Certificate cannot be tied to your material | Photograph vial and certificate together |
| No method section | The number is not reproducible | Request column, gradient, wavelength |
| Purity to two decimals, no chromatogram | False precision | Request the trace |
| Test date before manufacture date | Certificate belongs to a different lot | Compare dates |
| Identical figures across lots | One certificate reused | Compare two lots side by side |
| “Sterile filtered” with no sterility test | Process claim substituted for a result | Ask for the sterility report |
The underlying point is that sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.
Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.
Price per milligram of measured peptide, not per milligram of label claim.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsThis is the question where methodology matters more than the conclusion.
To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.
In practice, cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.
The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.
Use a fixed documentation checklist rather than an impression.
Start by asking what you are optimising for, because cost per milligram, documentation depth and lead time do not have a common winner.
Lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.
Put another way, publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Compare content, not purity. Purity clusters and content does not.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.